SMSima Mozafari

Sima Mozafari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sima Mozafari has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association Between Dietary Habits and Their Scores With the 9.9‐Year Incidence of Dyslipidemia in an Urban Adult Population: Findings From a Prospective Cohort Study

    by Mohammadtaghi Sarebanhassanabadi, Abolfazl Mohammadi, Pedro Marques‐Vidal, Seyedmostafa Seyedhosseini, Seyedeh Mahdieh Namayandeh, Hanieh Montazeri Hedesh, Sima Mozafari

    Dyslipidemia elevates the risk of metabolic disorders and cardiovascular disease (CVD). While various dietary and lifestyle factors contribute to dyslipidemia, healthier eating habits may decrease this risk. This longitudinal study investigated the association between dietary habits score (DHS) and the 9.9‐year risk of dyslipidemia among urban adults. A total of 1042 adults without dyslipidemia at baseline were enrolled, and 693 participants who completed follow‐up were included in the final analysis. Dietary habits were assessed in 2005–2006, and participants were followed for an average of 9.9 years. DHS was calculated for each participant by summing the hazard ratios (HRs) associated with individual dietary habits in relation to dyslipidemia risk, thereby generating a cumulative score reflecting overall dietary habits quality. A higher DHS indicates unhealthier dietary habits. The association between DHS and the incidence of dyslipidemia was analyzed using Cox regression. During the 9.9‐year follow‐up, the incidence of dyslipidemia was 65.8%. After adjustment for confounders, the incidence of dyslipidemia (HR; 95% CI) was found to be associated with poor weight management (HR = 1.68; 95% CI: 1.14–2.47), low salad consumption (HR = 2.46; 95% CI: 1.56–3.90), and frequent fast‐food intake (HR = 1.90; 95% CI: 1.08–3.34). Overall, individuals in the highest DHS quartile exhibited a greater risk of dyslipidemia (HR = 2.58; 95% CI: 1.50–4.43, p = 0.001) compared with the lowest quartile of DHS. The same positive association was found in males (HR = 3.56; 95% CI: 1.95–6.51, p = 0.034). The findings indicate a significant positive association between poor weight management, low salad consumption, frequent fast‐food intake, and higher DHS with the 9.9‐year incidence of dyslipidemia. Further large‐scale prospective studies are needed to validate these findings.

  • Open Access

    In Silico and In Vitro Analyses of PNPLA3 rs738409 C>G Polymorphism in Patients With Non-alcoholic Fatty Liver Disease

    by Fatemeh Safari, Zeinab Imani-Saber, Sima Mozafari, Saeed Lotfi, Nahid Einollahi

    Background: The polymorphism associated with liver fat content, which is well-known as PNPLA3 rs738409 (Patatin-like phospholipase domain-containing protein 3), is one of the critical subjects widely investigated in the literature regarding the prevalence of non-alcoholic fatty liver disease (NAFLD) worldwide. The present research aimed to study the bioinformatics investigations of this polymorphism together with the in vitro analyses among patients with NAFLD. Materials and Methods: In this case-control study, after performing bioinformatics analysis, the laboratory examination was performed in several steps. Genomic DNA was extracted from the blood of 53 NAFLD patients and 107 subjects with normal liver ultrasounds. PNPLA3 rs738409 was genotyped by the polymerase chain reaction-restriction fragment length polymorphism method. The laboratory test results, including fasting blood sugar, triglyceride, cholesterol, high-density lipoprotein, low-density lipoprotein, alanine aminotransferase, and aspartate aminotransferase were collected from medical records. Finally, statistical analysis was performed using SPSS software, version 18.0. Results: The frequency of the G allele was 56% and 36% among patients and in the control group, respectively. The frequency of genotypes was 35.8% and 47.7% (CC), 17% and 31.8% (CG), 47.2% and 20.6% (GG) in patients and control groups, respectively. The adjusted odds ratios for PNPLA3 rs738409 C>G were 3.0 (95% confidence interval [CI]: 1.28-6.98, P=.011) and 0.68 (95% CI: 0.25- 1.83, P = .44) for GG and CG genotypes, respectively. Conclusion: The findings showed the association between the GG genotype and the presence of NAFLD. Furthermore, the bioinformatics findings suggested the probable risk of the disease incidence regarding the change of hydropathic characteristics resulting from the amino acid substitution.

  • Open Access

    Investigating the Antimicrobial Activity of Vancomycin-Loaded Soy Protein Nanoparticles

    by Hadi Zare-Zardini, Hossein Soltaninejad, Adel Ghorani-Azam, Mohammad Javad Forouzani-Moghaddam, Sima Mozafri, Zohreh Akhoundi-Meybodi, Farzad Ferdosian, Fatemeh Jabinian

    Developing targeted and slow-release antibiotic delivery systems can effectively reduce drug overdose and side effects. This study aimed to investigate the antimicrobial activity of vancomycin-loaded soy protein nanoparticles (vancomycin-SPNs). For the preparation of SPNs, the desolvation method was applied in different concentrations of vancomycin and soy protein (15:5, 10:15, 6:20, 8:25, and 10:30 of vancomycin:soy protein). Scanning electron microscope (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and FTIR were used for nanoparticle characterization. Antibacterial activity was evaluated by the radial diffusion assay (RDA) and absorbance methods. Proper synthesis was demonstrated by characterization. The best drug loading (% entrapment efficiency = 90.2%), the fastest release rate (% release = 88.2%), and the best antibacterial activity were observed in ratio 10:30 of vancomycin:SPNs. Results showed that SPNs are a potent delivery system for antibiotic loading and slow release to control antibiotic use.